Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/jspui/handle/10553/153719
DC FieldValueLanguage
dc.contributor.authorClavo Varas, Bernardinoen_US
dc.contributor.authorCordoba-Lanus, Elizabethen_US
dc.contributor.authorMartinez-Sanchez, Gregorioen_US
dc.contributor.authorFederico, Marioen_US
dc.contributor.authorCanovas-Molina, Angelesen_US
dc.contributor.authorPinero, Jose E.en_US
dc.contributor.authorVargas-Prado, Ana M.en_US
dc.contributor.authorRamchandani, Avinashen_US
dc.contributor.authorZajac, Martaen_US
dc.contributor.authorRibeiro, Ivoneen_US
dc.contributor.authorNavarro, Minervaen_US
dc.contributor.authorJorge, Ignacio J.en_US
dc.contributor.authorGonzalez-Martin, Jesus M.en_US
dc.contributor.authorMartin-Alfaro, Ruthen_US
dc.contributor.authorFernandez-Tagarro, Mariaen_US
dc.contributor.authorDiaz-Garrido, Juan A.en_US
dc.contributor.authorLorenzo-Morales, Jacoben_US
dc.contributor.authorRodríguez Esparragón, Francisco Javieren_US
dc.date.accessioned2025-12-16T16:49:05Z-
dc.date.available2025-12-16T16:49:05Z-
dc.date.issued2025en_US
dc.identifier.issn2077-0383en_US
dc.identifier.otherWoS-
dc.identifier.urihttps://accedacris.ulpgc.es/jspui/handle/10553/153719-
dc.description.abstractBackground: Chronic pelvic toxicity induced by radiotherapy and/or chemotherapy (R/CIPT) is a debilitating sequela in gynecological cancer survivors, often refractory to conventional treatments and potentially linked to gut microbiota dysbiosis. Ozone therapy (OT), particularly rectal insufflation, demonstrates anti-inflammatory and redox-modulating effects through hormetic mechanisms (Nrf2 activation/NF-kappa B inhibition). We hypothesize that its clinical benefit is mediated, in part, by restoring gut microbial homeostasis. Objective: This manuscript proposes a clinical study to evaluate the impact of rectal OT on the gut microbiota of patients with gynecological cancers and chronic R/CIPT. Proposed Methods: A prospective, observational study of 38 patients is outlined: 19 with CTCAE v5.0 Grade >= 2 chronic R/CIPT receiving compassionate rectal OT (similar to 40 sessions over 4 months), and 19 matched controls without toxicity. Stool samples for 16S rRNA sequencing will be collected from the OT group pre- and post-intervention and once from controls. Primary endpoints are changes in microbiota composition/diversity and pelvic toxicity scores (CTCAE v5.0, EORTC QLQ-CX24). Secondary endpoints include quality of life (EORTC QLQ-C30, EQ-5D-5L), anxiety/depression (HADS), and serum inflammatory/oxidative stress biomarker analysis. Anticipated Results and Conclusion: This will be the first study to prospectively investigate whether rectal OT's effect correlates with a beneficial shift in the gut microbiota, specifically an increase in commensals (e.g., short-chain fatty acids producers) and a decrease in pathobionts. If successful, OT could be assessed as a novel, microbiota-targeting intervention for R/CIPT. The findings from this pilot study will provide the necessary groundwork for a future randomized controlled trial to definitively establish causality and efficacy.en_US
dc.languageengen_US
dc.relation.ispartofJournal of Clinical Medicineen_US
dc.sourceJournal Of Clinical Medicine [eISSN 2077-0383] ,v. 14 (22), (Noviembre 2025)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3201 Ciencias clínicasen_US
dc.subject320713 Oncologíaen_US
dc.subject320108 Ginecologíaen_US
dc.subject320112 Radioterapiaen_US
dc.subject320806 Quimioterapiaen_US
dc.subject.otherChemotherapyen_US
dc.subject.otherTherapyen_US
dc.subject.otherOzone Therapyen_US
dc.subject.otherGut Microbiotaen_US
dc.subject.otherGynecological Canceren_US
dc.subject.otherRadiotherapy Toxicityen_US
dc.subject.otherChemotherapy Toxicityen_US
dc.subject.otherDysbiosisen_US
dc.subject.otherSupportive Careen_US
dc.titleModulating the Gut Microbiota via Rectal Ozone Insufflation in Gynecological Cancer Patients with Radiotherapy/Chemotherapy-Induced Pelvic Toxicity: A Proposed Clinical Study Protocolen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.3390/jcm14228015en_US
dc.identifier.isi001625668000001-
dc.identifier.eissn2077-0383-
dc.identifier.issue22-
dc.relation.volume14en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.description.numberofpages15en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Clavo, B-
dc.contributor.wosstandardWOS:Cordoba-Lanús, E-
dc.contributor.wosstandardWOS:Martínez-Sánchez, G-
dc.contributor.wosstandardWOS:Federico, M-
dc.contributor.wosstandardWOS:Cánovas-Molina, A-
dc.contributor.wosstandardWOS:Piñero, JE-
dc.contributor.wosstandardWOS:Vargas-Prado, AM-
dc.contributor.wosstandardWOS:Ramchandani, A-
dc.contributor.wosstandardWOS:Zajac, M-
dc.contributor.wosstandardWOS:Ribeiro, I-
dc.contributor.wosstandardWOS:Navarro, M-
dc.contributor.wosstandardWOS:Jorge, IJ-
dc.contributor.wosstandardWOS:González-Martín, JM-
dc.contributor.wosstandardWOS:Martín-Alfaro, R-
dc.contributor.wosstandardWOS:Fernández-Tagarro, M-
dc.contributor.wosstandardWOS:Díaz-Garrido, JA-
dc.contributor.wosstandardWOS:Lorenzo-Morales, J-
dc.contributor.wosstandardWOS:Rodríguez-Esparragon, F-
dc.date.coverdateNoviembre 2025en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,919
dc.description.jcr2,9
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds10,5
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUSA-ONEHEALTH 5: Reproducción Animal, Oncología y Anestesiología Comparadas-
crisitem.author.deptIU de Sanidad Animal y Seguridad Alimentaria-
crisitem.author.orcid0000-0003-2522-1064-
crisitem.author.orcid0000-0003-1663-3673-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Sanidad Animal y Seguridad Alimentaria-
crisitem.author.fullNameClavo Varas, Bernardino-
crisitem.author.fullNameRodríguez Esparragón, Francisco Javier-
Appears in Collections:Artículos
Adobe PDF (530,24 kB)
Show simple item record

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.